Image Credit: Government Pharmaceutical Organisation

Patent for Favipiravir rejected in Thailand

A patent application for Japanese-made anti-viral drug Favipiravir has been rejected by Thailand’s Intellectual Property Department over its manufacturing quality. The department’s director-general, Mr. Vuttikrai Leewiraphan, said yesterday (Wednesday) that…

Read More
Thailand pulmonologist COVID-19
(Photo by JOEL SAGET / AFP)

PM insists 61 million doses of COVID vaccines this year should be enough for Thailand

Thailand will have procured up to 61 million doses of COVID-19 vaccines by the end of this year, which should be sufficient to cope with the pandemic, said Prime Minister…

Read More

With few vaccines, Thailand relies on Favipiravir in battle against COVID

Although most COVID-19 patients in Thailand will not be treated with Favipiravir since their symptoms are too mild, the country is still using more than 20,000 pills of this antiviral…

Read More
Dr. Opas Karnkavinpong, director-general of the Disease Control Department

Thai government to procure two million Favipiravir anti-viral tablets

Thailand’s Government Pharmaceutical Organization (GPO) has recently entered into contract negotiations to procure one million tablets of Favipiravir, and anti-viral drug used in the treatment of COVID-19 patients, and is…

Read More
File photo

Thai GPO to produce anti-viral Favipiravir next year

Thailand is expected to be able to produce the anti-viral drug, Favipiravir, early next year, Mrs. Nanthakarn Suwanpidokkul, a special specialist attached to the Government Pharmaceutical Organization (GPO), said today….

Read More

Page 1 of 1

Login

Welcome! Login in to your account

Remember me Lost your password?

Lost Password